HON
- Removed from S&P 100 on Sep 9, triggering passive-fund selling pressure.
- Aerospace division slashed growth forecast on Aug 5 due to supply chain issues.
- Quantinuum IPO (upsized to $1.68B) and 13% first-day rise provide a valuation cushion.
- GE's $12B acquisition of supplier CPP poses long-term competitive risk despite contract commitments.
News situation · 8 items / 30 D
No official disclosure in this window — everything below is reporting about HON, not from it.
Honeywell faces a mixed fundamental landscape. Its removal from the S&P 100 on September 9 has set off forced selling by passive index funds, a mechanical overhang that dominates the next several days.
Read full analysis
The aerospace division compounded the bearish tone by cutting its growth forecast on August 5, citing supply chain disruptions, which directly raises concerns about revenue and margin momentum. Offsetting these negatives, capital-market events provide partial support: the Quantinuum IPO raised an upsized $1.68 billion and surged 13% on day one, boosting the mark-to-market value of Honeywell's stake, while the spinoff sold to Brady for $800 million sharpens the portfolio focus. GE's $12 billion acquisition of supplier CPP introduces a long-term competitive risk despite GE's pledge to honor third-party contracts; near-term supply appears intact, but the potential for prioritized allocation to GE remains a watch item. Honeywell also underperformed 3M over the past year, with a three-month decline against a 10% gain for 3M, underscoring broader sentiment. With no technical signals in this assessment, the overall neutral stance reflects the trade-off between bearish index-flow and operational pressures and supportive strategic moves.
Supporting factors
- Quantinuum IPO upsized to $1.68B with 13% first-day surge, boosting valuation of Honeywell's stake.
- Spinoff sold to Brady for $800 million refocuses portfolio on core industrials.
- Susquehanna initiated coverage of Honeywell Aerospace with Positive view on growth and margins.
- Solstice brand sees AI-driven demand as a generational opportunity for PFAS chemicals.
- GE's commitment to maintain third-party supply contracts keeps near-term supply chain intact.
Risks and what to watch
- S&P 100 removal forces passive-fund selling over coming days.
- Aerospace division cut its growth forecast on August 5 amid supply chain disruptions.
- Stock underperformed 3M over the past year; 3M gained 10% over three months while Honeywell declined.
- GE's ownership of CPP creates long-term competitive risk; supplier allocation may favor GE.
- Potential prioritization of supply to GE Aerospace over third parties.
Why was Honeywell removed from the S&P 100?
Honeywell was removed from the S&P 100 index on September 9. This is a benchmark membership change that forces passive funds tracking the index to sell their Honeywell positions, creating near-term selling pressure. The removal typically reflects a decline in the stock's market capitalization rank among the largest U.S. companies. While it does not reflect a change in Honeywell's underlying business fundamentals, it mechanically affects share supply and demand in the short term.
How does the Quantinuum IPO impact Honeywell?
Honeywell’s strategic backing of Quantinuum resulted in an upsized $1.68 billion IPO, and the stock rose 13% on its first day. This provides a mark-to-market uplift on Honeywell’s equity stake, offering a modest valuation cushion. However, the quantum unit remains a small part of Honeywell's overall portfolio, so the direct financial impact on earnings is limited. The IPO also demonstrates Honeywell’s ability to monetize ventures, which aligns with its portfolio streamlining efforts.
What does GE's acquisition of CPP mean for Honeywell?
GE Aerospace acquired CPP, a key Honeywell supplier, for $12 billion. GE has committed to maintaining third-party contracts, so near-term supply to Honeywell should continue without disruption. However, in the long term, having a direct industrial competitor own a critical supplier introduces risks: GE might prioritize its own requirements during tight supply periods, or use the relationship to gain cost or access advantages. This creates a structural competitive concern for Honeywell's aerospace supply chain.
What are the main short-term risks for Honeywell?
The dominant near-term risk is forced selling from passive funds after Honeywell's removal from the S&P 100, which could pressure the stock for several days. Additionally, the aerospace division cut its growth forecast on August 5 due to supply chain disruptions, signaling weaker revenue and margin pressure. The stock has also underperformed 3M over the past year, with a three-month decline while 3M gained 10%, reflecting broader market sentiment.
Both worlds over time
Technical and news signals of the last 30 days on one timeline.
HON fundamental outlook?
From news analysis — different time windows than the trading horizons above
Bearish index-rebalancing flows dominate the next 1-7 days, as passive S&P 100 funds complete their forced HON sales. The stock tests recent support levels, with limited offset from the Quantinuum mark-to-market uplift.
Over 1-4 weeks, selling pressure from index deletion eases, shifting focus to aerospace supply-chain updates and any additional portfolio-shaping moves. The Quantinuum stake provides a small valuation cushion, while GE’s CPP ownership begins to surface as a supplier-concentration risk.
The 1-3 month outlook is shaped by structural portfolio repositioning and a more competitive aerospace supply landscape. The spinoff and quantum monetization advance Honeywell’s focus on core industrials, but GE’s control of a critical supplier and the aerospace division’s growth reset weigh on earnings visibility.
What is being reported about HON
📝 Overview Generated automatically?
HON has been the subject of 14 signals across 14 articles in the last 365 days. Sentiment skews Bullish (36%).
Breakdown: 5 bullish, 4 bearish, 5 neutral. AI confidence averages 56% across all signals.
Most-cited catalysts: Quantinuum's IPO filing unlocks value for Honeywell's quantum investment (1×), Positive market reception could lift Honeywell shares (1×), Quantinuum’s upsized IPO target may boost the mark-to-market valuation of Honeywell’s stake. (1×). Most-cited risk factors: Adverse IPO market conditions could delay or reduce the offering (1×), Quantinuum's high cash burn may concern investors (1×), Quantinuum may fail to sell shares at the higher target if investor demand softens. (1×).
Related assets
Same category or comparable signal picture — each card opens the full cockpit.